)
)
Bio Vitos Pharma Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Bio Vitos Pharma
Access all reports
Bio Vitos Pharma AB, previously known as Hemcheck Sweden AB, is a medical technology company based in Sweden. The company specializes in developing and commercializing solutions for the detection of hemolysis in blood samples. Their primary product is a combination of disposable tests and readers designed to quickly identify hemolyzed blood samples in vacuum tubes and blood gas syringes. This technology aims to enhance patient safety, streamline healthcare processes, and reduce costs by ensuring accurate blood sample analysis. Bio Vitos Pharma serves the healthcare sector, particularly targeting emergency departments in Europe and the United States. The company is headquartered in Solna, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
BIOVIT
Country
🇸🇪 Sweden